Patent · US Active

Inhibiting agents for Bruton's tyrosine kinase

US12240838B2 · kind B2 · utility

0Cited by
1References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 15, 2020
Grant dateMar 4, 2025
Priority date
Expiry dateJun 17, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D417/12
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Provided are compounds of Formula (I), or pharmaceutically acceptable salts thereof, and methods for their use and production.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.